None The WISeR: New Medicare AI Leaves Neurotech In Denial

Despite its growing “deeptech” bonafides, the US neurotechnology industry has wound up on the wrong side of AI.

The Centers for Medicare and Medicaid Services (CMS) announced a new pilot program to test whether AI-enabled claim denials will save money. How? By automatically reducing the use of implanted neurostimulation and other service categories "that may be fraudulent, and wasteful, or of low-value and medically unnecessary."

The Wasteful and Inappropriate Service Reduction ( WISeR ) Model is an initiative from the Center for Medicare and Medicaid Innovation (CMMI). Key details:

What: Reimbursement claims for 17 specific services, including six implanted neurotech treatments, will be automatically flagged for further medical review using AI. Physicians will receive a cut of the